http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1722398

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 573
issn 1365-2125
0306-5251
issueIdentifier 4
pageRange 561-573
publicationName British Journal of Clinical Pharmacology
startingPage 561
bibliographicCitation Ternant D, Hénin E, Cartron G, Tod M, Paintaud G, Girard P. Development of a drug–disease simulation model for rituximab in follicular non‐Hodgkin's lymphoma. Brit J Clinical Pharma. 2009 Oct;68(4):561–73. doi: 10.1111/j.1365-2125.2009.03494.x.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_54c0775c60896358aa64a0aab1486ffa
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0158-1356
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d232ff423d011ded6c680583fe846066
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aead1f074ad80b7cd6840f991944040f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e947773a7ba2985e5bbbbd18e2f09239
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb22ad75c9c29a0503344a4566ed2afc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_43437dc6a25bb3a52c2ba1ccde9ad81b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0659-9635
date 200910
identifier https://pubmed.ncbi.nlm.nih.gov/PMC2780281
https://doi.org/10.1111/j.1365-2125.2009.03494.x
https://pubmed.ncbi.nlm.nih.gov/19843059
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1743
https://portal.issn.org/resource/ISSN/0306-5251
https://portal.issn.org/resource/ISSN/1365-2125
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Development of a drug–disease simulation model for rituximab in follicular non‐Hodgkin's lymphoma
discusses http://id.nlm.nih.gov/mesh/M0006784
http://id.nlm.nih.gov/mesh/M0480489
http://id.nlm.nih.gov/mesh/M0001357
http://id.nlm.nih.gov/mesh/M0022676
http://id.nlm.nih.gov/mesh/M0544940
http://id.nlm.nih.gov/mesh/M0017465
http://id.nlm.nih.gov/mesh/M0244307
http://id.nlm.nih.gov/mesh/M0005485
http://id.nlm.nih.gov/mesh/M0026482
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000911Q000493
http://id.nlm.nih.gov/mesh/D000971Q000493
http://id.nlm.nih.gov/mesh/D008224Q000188
http://id.nlm.nih.gov/mesh/D008228Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000971Q000494
http://id.nlm.nih.gov/mesh/D000971Q000008
http://id.nlm.nih.gov/mesh/D016032
http://id.nlm.nih.gov/mesh/D008962
http://id.nlm.nih.gov/mesh/D000369
http://id.nlm.nih.gov/mesh/D011241Q000008
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D055815
http://id.nlm.nih.gov/mesh/D018572
http://id.nlm.nih.gov/mesh/D004317
http://id.nlm.nih.gov/mesh/D000911Q000494
http://id.nlm.nih.gov/mesh/D003520Q000008
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D058846
http://id.nlm.nih.gov/mesh/D000911Q000008
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D017452
http://id.nlm.nih.gov/mesh/D014750Q000008
http://id.nlm.nih.gov/mesh/D000293
http://id.nlm.nih.gov/mesh/D000069283
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45358158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134755071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3717450
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164145
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296921
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8390
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9a784dff46ed44d6c0b5f4ad7f906f62
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8389

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135789409
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2214

Total number of triples: 80.